|
Validated in-hospital insulin protocols: Portland and Yale.
|
|
|
|
CME Newsletter, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the Evidence-Based Recommendations in Hyperglycemia and Acute Coronary Syndromes Clinical
Workshop series held in 8 cities across the United States.
The goals of the Clinical Workshop series were to:
-
Discuss the evidence that led to the development of the 7 recommendations published in the
2008 American Heart Association (AHA) Scientific Statement on Hyperglycemia and Acute Coronary Syndromes (ACS)
-
Review the critical gaps in clinical evidence around the current inpatient hyperglycemia treatment paradigm
-
Foster an open dialogue on the practical aspects of in-hospital glucose monitoring and management in both
diabetic and nondiabetic patients
-
Reinforce the need to engage the healthcare team (ie, physicians and critical care nurses) in ensuring
successful implementation of insulin infusion protocols
-
Identify barriers to successful protocol implementation
Clinical Workshop host cities were identified as regions of interest through a clinical practice needs assessment
with an emphasis on identifying regional practice strengths and weaknesses.
|
|
|
Baltimore Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in Baltimore,
Maryland, on March 4, 2009. The goal of the workshop was to discuss the
clinical rationale for treating hyperglycemia in ACS patients with and
without diabetes and to address critical gaps in current treatment paradigms.
The Baltimore/Washington, DC, area was identified as a
region of interest through a pre-meeting geographic needs assessment.
|
|
|
Brooklyn Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in Brooklyn,
New York, on March 25 2009. The goal of the workshop was to discuss the
clinical rationale for treating hyperglycemia in ACS patients with and
without diabetes and to address critical gaps in current treatment paradigms.
The New York metropolitan area was identified as a
region of interest through a pre-meeting geographic needs assessment.
|
|
|
Birmingham Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in Birmingham, Michigan, on
April 15, 2009. The goal of the workshop was to discuss the
clinical rationale for treating hyperglycemia in ACS patients with and
without diabetes and to address critical gaps in current treatment paradigms.
The Detroit area was identified as a
region of interest through a pre-meeting geographic needs assessment.
|
|
|
Cleveland Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in Cleveland, Ohio, on April 21, 2009.
The goals of the workshop were to discuss the clinical rationale for treating
hyperglycemia in ACS patients with and without diabetes and to address critical
gaps in current treatment paradigms. The Cleveland area was identified as a
region of interest through a pre-meeting geographic needs assessment.
|
|
|
Atlanta Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in Atlanta, Georgia, on April 21, 2009.
The goals of the workshop were to discuss the clinical rationale for treating
hyperglycemia in ACS patients with and without diabetes and to address critical
gaps in current treatment paradigms. The Southeast was identified as a region of
interest through a pre-meeting geographic needs assessment.
|
|
|
Miami Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in in Miami, Florida, on April 28, 2009.
The goals of the workshop were to discuss the clinical rationale for treating
hyperglycemia in ACS patients with and without diabetes and to address critical
gaps in current treatment paradigms. The South Florida metropolitan area was identified as a region of
interest through a pre-meeting geographic needs assessment.
|
|
|
San Antonio Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in San Antonio, Texas, on May 6, 2009.
The goals of the workshop were to discuss the clinical rationale for treating
hyperglycemia in ACS patients with and without diabetes and to address critical
gaps in current treatment paradigms. The San Antonio area was identified as a region of
interest through a pre-meeting geographic needs assessment.
|
|
|
San Jose Report, 2009
The Vascular Biology Working GroupSM (VBWG) is pleased to present the
results of the first Evidence-Based Recommendations in
Hyperglycemia and ACS Clinical Workshop, held in San Jose, California, on June 17, 2009.
The goals of the workshop were to discuss the clinical rationale for treating
hyperglycemia in ACS patients with and without diabetes and to address critical
gaps in current treatment paradigms. The San Jose area was identified as a region of
interest through a pre-meeting geographic needs assessment.
|
|
|
